메뉴 건너뛰기




Volumn 11, Issue 6, 2000, Pages 753-756

Malignant peritoneal mesothelioma treated by continuous hyperthermic peritoneal perfusion chemotherapy

Author keywords

Hyperthermia; Malignant mesothelioma; Peritoneal perfusion chemotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; MITOMYCIN C; PACLITAXEL; SURAMIN;

EID: 0033752489     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008328120555     Document Type: Article
Times cited : (20)

References (24)
  • 1
    • 0001971137 scopus 로고
    • Benign and malignant mesothelioma
    • DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia: J.B. Lippincott
    • (1993) , pp. 1489-1508
    • Antman, K.H.1    Pass, H.I.2    DeLaney, T.3
  • 19
    • 0029868030 scopus 로고    scopus 로고
    • Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma: Report of a phase I-II study of weekly cisplatin/interferon alfa-2a
    • (1996) J Clin Oncol , vol.14 , pp. 878-885
    • Soulie, P.1    Ruffie, P.2    Trandafir, L.3
  • 22
    • 0027177546 scopus 로고
    • Relation between clinical and histologic outcome of intraperitoneal hyperthermic perfusion for patients with gastric cancer and peritoneal metastasis
    • (1993) Oncology , vol.50 , pp. 338-343
    • Fujimoto, S.1    Takahashi, M.2    Kobayashi, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.